核桃胜肽粉適用於植物性胜肽補充劑、飲品粉、膠囊、錠劑、軟糖及客製化預混粉。該產品不應被宣傳為經證實可治療記憶障礙、阿茲海默症、高血壓、焦慮、失眠、心血管疾病或其他醫療狀況的療法。.

什麼是核桃胜肽?
核桃胜肽是由核桃蛋白(通常取自核桃仁、脱脂核桃粕或核桃蛋白分餾物)製成的短鏈胺基酸混合物。其典型製造流程包括蛋白質萃取、受控的酶解、酶失活、過濾或膜分離、濃縮、乾燥,以及最終的粉末標準化。.
核桃胜肽的相關搜尋詞還包括 核桃胜肽粉、核桃蛋白水解物、水解核桃蛋白、核桃寡胜肽、核桃蛋白胜肽、, 和 皇家胡桃肽. 這些名稱可能有所重疊,但買家不應假設每種產品的肽含量、分子量分布、水解度或生物活性皆相同。.
正在評估的品牌 核桃胜肽粉(大宗) 應將現行規格與該批次的分析報告進行比對,而非僅依賴產品名稱。.
核桃胜肽 vs 核桃蛋白 vs 核桃萃取物
| 材質 | 生產過程 | 主要成分 | B2B 關鍵問題 |
|---|---|---|---|
| 核桃肽 | 核桃蛋白經水解後,會分解成較短的胜肽組分 | 肽、殘留的完整蛋白質及游離胺基酸,視製程而定 | 肽分析、分子量分布、蛋白質檢測結果及水解程度分別為何? |
| 核桃蛋白 | 蛋白質在未經同等程度水解的情況下被萃取/濃縮 | 較大的核桃蛋白分餾物 | 何謂蛋白質測定、胺基酸組成、消化率及分散性? |
| 核桃萃取物 | 從核桃材料中萃取出特定可溶性化合物或標記化合物 | 這取決於萃取溶劑、載體、比例以及目標化合物 | 究竟萃取了什麼、標記物是什麼,以及萃取率是多少? |
水解核桃萃取物 這是一個含義模糊的商業術語。若該物質是透過水解核桃蛋白所製成,其功能上可能更接近核桃蛋白水解物;若屬植物萃取物或化妝品萃取物,其成分則可能截然不同。供應商的規格說明應明確界定原料來源、製程路徑、蛋白質/胜肽含量,以及預期用途。.
核桃胜肽粉是如何製成的?
- 核桃原料的準備: 果仁、壓榨餅或脫脂核桃粉均經過清潔並符合品質標準。.
- 減油: 可去除殘留的核桃油,以提高蛋白質濃度並確保製程的一致性。.
- 蛋白質萃取: 利用 pH 值、溫度及分離條件來回收核桃蛋白分餾物。.
- 酶解: 特定蛋白酶會將較大的蛋白質分解成肽混合物。.
- 分離: 可採用離心、膜過濾或超濾等方法,以篩選出特定分子量範圍的肽。.
- 濃縮與乾燥: 該胜肽溶液會被濃縮並轉化為粉末,通常透過噴霧乾燥或其他經驗證的乾燥製程來完成。.
- 標準化與品質控制: 本文綜述了胜肽/蛋白質分析、分子量分布、水分、雜質、微生物學、感官特性以及過敏原相關文件等內容。.
製程至關重要,因為水解條件會改變胜肽序列的分布、苦味、溶解度、游離胺基酸含量以及生物活性。因此,「核桃胜肽」是一類水解產物,而非單一化學物質。.
較小的核桃胜肽吸收效果總是更好嗎?
未必如此。較短的胜肽確實可能改變其溶解度與消化行為,但「分子量較小」不應被視為具有更佳人體生物利用度或臨床療效的絕對證明。.
一項 2020 年的模擬胃腸道消化研究,將脫脂核桃粉與經 Alcalase 處理的核桃粉水解物進行了比較。消化後,未經預水解的核桃粉同樣產生了大量分子量低於 3,000 Da 的胜肽及游離胺基酸。 研究作者指出,就測試的 ACE 抑制活性與 DPPH 自由基清除活性而言,兩種經消化處理的製劑之間並無顯著差異。這表明,至少在本次研究的條件下,預水解並非在消化過程中產生小分子胜肽的必要步驟。.
其他研究已鑑定出若干源自核桃的肽,這些肽在動物模型中給藥後可被檢測到。例如,一項 2024 年的小鼠研究指出,特定肽 TWLPLPR(TW-7)在經口灌胃後可進入血漿及腦組織。這為……提供了有用的機制證據。 該胜肽在小鼠體內; ;這並不能證明所有市售的核桃胜肽粉都能穿越人體血腦屏障,或具有相同的藥代動力學特性。.

核桃胜肽的益處:研究證據究竟顯示了什麼?
| 索賠範圍 | 證據類型 | 能說些什麼 | 不應主張的事項 |
|---|---|---|---|
| 認知/記憶 | 小型人體試驗 + 多項動物/細胞研究 | 研究人員已針對特定核桃寡肽製劑對記憶力/認知功能的影響進行了研究 | 請勿聲稱可治療或預防失智症、阿茲海默症或認知功能障礙 |
| 睡眠 | 一項關於核桃寡胜肽的小規模人體試驗;以及一項結合茶氨酸的較新組合療法試驗 | 雖然有早期人體試驗的證據,但產品的成分特性與其他成分仍至關重要 | 請勿宣稱「一般性核桃胜肽」能治療失眠 |
| 抗氧化活性 | 廣泛的體外/動物肽類研究 | 特定的水解物與胜肽序列在實驗模型中展現出抗氧化活性 | 請勿將 DPPH/ABTS 或細胞實驗結果直接解讀為經證實的疾病預防效果 |
| 血壓/ACE 抑制 | 體外胜肽篩選 + 動物實驗 | 已鑑定出具有ACE抑制活性的核桃來源胜肽 | 請勿宣稱一般性的核桃胜肽能降低血壓或治療高血壓 |
| 抗發炎效果 | 主要處於臨床前階段 | 某些特定的核桃胜肽模型會影響發炎途徑 | 請勿聲稱可治療發炎性疾病 |
| 肌膚/抗老化 | 間接/機制性證據與成分類別證據 | 蛋白質胜肽雖可應用於美容配方中,但仍需針對特定產品的實證支持 | 若無直接實證支持,請勿宣稱具有消除皺紋、修復肌膚或抗衰老的功效 |

核桃胜肽對大腦健康與記憶的影響:人類與動物研究證據之比較
人體研究證據:前景看好,但樣本量極小
一項於 2022 年進行的隨機、雙盲、安慰劑對照試驗,針對 18 名青少年及 18 名年長者,評估了一種特定的核桃寡肽。 受試者被分配至安慰劑組、每日170毫克組或每日340毫克組,為期90天;在每個年齡組中,各劑量組最初僅有六名受試者。研究報告指出,多項認知測驗分數及匹茲堡睡眠品質指數分數均有所改善。.
這項研究具有重要意義,因為它直接在人體上測試了口服核桃寡肽。然而,該研究 small, short, and product-specific. It should be treated as preliminary human evidence rather than proof that any walnut peptide powder improves memory, intelligence, or sleep.
動物實驗與機制性證據:研究基礎更為廣泛
Multiple mouse, rat, zebrafish, cell, and peptide-identification studies have explored walnut-derived peptides for learning, memory, oxidative stress, synaptic signaling, and neuroprotection. Recent studies have reported effects from specific peptide sequences such as TW-7 and other isolated peptides in animal models.
This is useful for research and ingredient development, but it is lower-level evidence for consumer health claims than replicated randomized human trials using the same commercial ingredient.
2026 年核桃胜肽+茶氨酸人體試驗有何意義?
A 2026 Food & Function study used an eight-week randomized, placebo-controlled human trial as part of a multi-species research program. The intervention was a combination of walnut peptide and theanine. The study reported improvements in sleep duration and subjective sleep-quality scores in adults with sleep disturbances.
This does not establish the effect of walnut peptide alone because the intervention contained theanine. Supplement brands should not cite a combination trial as proof that a single-ingredient walnut peptide powder produces the same outcome.
關於核桃胜肽的抗氧化與血壓研究
Walnut protein hydrolysates and isolated walnut peptides have produced antioxidant and ACE-inhibitory activity in laboratory studies. Individual ACE-inhibitory peptide sequences have been isolated and characterized, and newer research continues to optimize walnut protein hydrolysis for these activities.
The main compliance limitation is the evidence level. An in-vitro ACE-inhibition percentage or IC50 value is not the same as a demonstrated reduction in human blood pressure. Likewise, DPPH or ABTS radical-scavenging capacity is not proof that a finished supplement prevents cardiovascular disease, cancer, neurodegenerative disease, or biological aging.
For product development, the correct approach is to connect a proposed claim to the exact walnut peptide material, human dose, finished dosage form, and relevant clinical endpoint.
核桃胜肽粉在營養補充劑配方中的應用
Walnut peptide can be considered for:
- single-ingredient plant peptide powders;
- capsules and tablets;
- sachets and stick packs;
- functional drink powders;
- plant-protein and peptide premixes;
- beauty-from-within or healthy-aging concepts;
- cognitive or sleep-support formulas where the full claim package is appropriately substantiated;
- multi-ingredient formulas developed through 客製化補充劑配方.
Walnut peptide is not simply a high-protein replacement for soy, pea, rice, or whey protein. Depending on grade, it may be used at much lower quantities and positioned around hydrolyzed plant peptides rather than bulk daily protein intake.
核桃胜肽是純素的嗎?
Walnut peptide is plant-derived, so the active raw material can fit a vegan formulation. However, a final vegan claim still depends on processing aids, carriers, excipients, capsule shell, flavors, cross-contact controls, and manufacturing documentation. Verify the full formula and manufacturing process rather than assuming that a walnut-derived raw material automatically makes the finished product vegan.
核桃過敏:最重要的安全與標示問題
Walnut is a tree nut and is a major food allergen in the United States. FDA allergen guidance requires the specific type of tree nut to be declared, meaning a walnut-derived protein or peptide ingredient cannot simply be treated as an unspecified “plant peptide.”
Hydrolysis does not automatically make a walnut-protein-derived ingredient non-allergenic. Unless a valid exemption or specific regulatory basis applies, brands should maintain walnut/tree-nut allergen declarations, supplier allergen statements, cross-contact controls, and finished-product label review.
People with walnut or tree-nut allergy should avoid walnut-peptide products unless the specific product has been evaluated by an appropriately qualified healthcare professional and its labeling supports use.
核桃胜肽粉 B2B 品質規格
| 規格 | 應提出哪些要求 | 為何重要 |
|---|---|---|
| 植物學鑑定 | Juglans regia or other declared walnut species/source | Identity, traceability, allergen and sourcing consistency |
| Starting material | Kernel, defatted meal, press cake, or extracted protein fraction | Affects composition and process consistency |
| Peptide assay | Peptide content, analytical method, acceptance range | Separates peptide-oriented grade from ordinary walnut protein |
| Protein assay | Protein %, test method, nitrogen conversion basis where relevant | Needed for composition and label calculations |
| 分子量分布 | Percent below defined Da ranges plus method | More useful than a vague “low molecular weight” claim |
| 水解度 | DH or supplier-defined hydrolysis process data where available | Influences peptide size, bitterness and solubility |
| 胺基酸組成 | Full profile and free-amino-acid contribution | Supports nutrition and batch consistency review |
| 溶解性/分散性 | Water solubility, sedimentation, pH response | Critical for beverages and powders |
| 感官特徵 | Color, odor, bitterness, walnut notes | Determines flavor-masking requirements |
| 過敏原 | Walnut/tree-nut allergen statement and cross-contact declaration | Required for U.S. label and risk review |
| 污染物 | Lead, cadmium, arsenic, mercury, microbiology and source-specific risks | Supplement raw-material safety |
| 物理規格 | Moisture, ash, mesh/particle size, bulk density | Manufacturing and shelf-life performance |
| 文件 | COA, specification, SDS/TDS, process flow, source statement, allergen statement, GMO/vegan documents as applicable | Procurement, regulatory and formulation review |

如何購買核桃胜肽粉:供應商檢查清單
For buyers searching for walnut peptide for sale, the lowest price per kilogram is not enough. Ask the supplier:
- Is this walnut peptide, walnut protein hydrolysate, or a walnut extract?
- What is the walnut species and starting material?
- What is the peptide assay and test method?
- What is the molecular-weight distribution, not just the average MW?
- What percentage is below 1,000 Da, 3,000 Da, or another relevant cutoff?
- What is the total protein and free-amino-acid content?
- What enzymes and processing aids are used?
- Is the product spray-dried, freeze-dried, or produced by another method?
- How soluble is it at the target serving concentration and pH?
- What are the bitterness and flavor-masking requirements?
- What walnut/tree-nut allergen documentation is supplied?
- Which heavy-metal and microbiological methods and limits are used?
- Are the clinical or functional claims based on this exact grade or only on unrelated walnut-peptide studies?
- What are MOQ, sample availability, packaging, lead time, shelf life, and storage conditions?
For a broader comparison of plant peptides and protein hydrolysates, buyers can review plant-based peptide ingredients and compare source, peptide content, MW, allergen status, solubility, and intended dosage form before final selection.
營養補充品品牌應如何定位核桃胜肽
The strongest defensible positioning is ingredient-specific:
- walnut-derived plant protein hydrolysate;
- defined peptide content and molecular-weight distribution;
- water-soluble or low-molecular-weight grade when supported by the specification;
- plant-derived peptide source;
- researched in cognitive, sleep, antioxidant, and ACE-inhibition models, with evidence level clearly stated;
- supported by batch COA, allergen and quality documentation.
Avoid phrases such as “treats Alzheimer’s disease,” “prevents dementia,” “lowers blood pressure,” “cures insomnia,” “reduces chronic inflammation,” “repairs neurons,” or “crosses the blood-brain barrier in humans” unless the exact product and claim meet the applicable regulatory and scientific standard.
常見問題
什麼是核桃胜肽?
Walnut peptide is a walnut-protein hydrolysate containing shorter peptide chains produced through controlled protein extraction and hydrolysis. Commercial products vary in peptide content, MW distribution, protein content, solubility, taste, and bioactivity.
核桃胜肽粉有何用途?
It is used as a specialty plant-derived peptide ingredient in supplements, capsules, tablets, sachets, drink powders, gummies, and functional nutrition premixes. The permitted finished-product claim depends on the exact formulation and evidence.
核桃胜肽有哪些益處?
Specific walnut peptides have been studied for cognitive, sleep, antioxidant, ACE-inhibitory, and neuroprotective effects. Most evidence is preclinical. A small 2022 human trial tested one walnut oligopeptide preparation, so broad benefits should be described cautiously.
核桃胜肽能改善記憶力嗎?
A very small 90-day randomized trial reported improvements in several cognitive measures with a specific walnut oligopeptide preparation, and animal studies are more numerous. The current evidence is not strong enough to claim that generic walnut peptide prevents or treats memory disorders.
核桃胜肽會穿越血腦屏障嗎?
A specific walnut-derived peptide, TW-7, was detected in mouse brain tissue after oral administration. This is animal evidence for one peptide and should not be generalized to every commercial walnut peptide powder or to humans.
核桃胜肽對睡眠有幫助嗎?
Early evidence exists. A small 2022 human trial evaluated walnut oligopeptide alone, and a 2026 randomized trial evaluated a walnut-peptide-plus-theanine combination. The combination study cannot prove that walnut peptide alone produces the same sleep effect.
核桃胜肽和核桃蛋白是一樣的嗎?
No. Walnut peptide is produced by hydrolyzing walnut protein into shorter chains. Walnut protein generally contains larger intact protein fractions. Compare peptide assay, MW distribution, protein content and solubility on the COA.
水解核桃萃取物與核桃胜肽是一樣的嗎?
Not always. “Hydrolyzed walnut extract” is an ambiguous name. Confirm whether the product is a hydrolyzed walnut protein, a botanical extract, or a cosmetic ingredient by checking the starting material, process, protein/peptide assay, and supplier specification.
核桃胜肽是純素的嗎?
The walnut-derived ingredient is plant-based, but a finished vegan claim also depends on processing aids, carriers, capsule shells, flavors, and manufacturing controls.
核桃胜肽對有堅果過敏的人來說安全嗎?
Walnut is a major tree-nut allergen. People with walnut/tree-nut allergy should avoid walnut-peptide products unless a qualified healthcare professional and the specific product labeling support otherwise.
買家在購買核桃胜肽粉前應檢查哪些事項?
Verify source identity, peptide and protein assays, MW distribution, amino-acid profile, solubility, sensory data, allergen statement, heavy metals, microbiology, processing route, COA, MOQ, packaging, lead time and evidence relevant to the intended claim.
參考資料
- Walnut (Juglans regia L.) Oligopeptide Effects on Memory, Cognition and Sleep Quality in a Randomized Double-Blind Controlled Trial
- Walnut peptide and theanine combination ameliorates sleep disorders: a multi-species study including a human trial
- Production, bioactivities and bioavailability of bioactive peptides derived from walnut origin by-products: a review
- Walnut proteolysis after simulated digestion: ACE inhibition and DPPH radical-scavenging activities
- Walnut-derived peptide TW-7 crosses the blood-brain barrier in a mouse model
- Purification and identification of an ACE inhibitory peptide from walnut protein
- ACE-inhibiting peptides from walnut protein isolate: in-silico and in-vitro study
- FDA: What is a Major Food Allergen?
- FDA: Declaring Specific Tree Nuts in Allergen Labeling
- 美國食品藥物管理局(FDA):結構/功能宣稱
- 聯邦貿易委員會(FTC):健康產品合規指引

萬華仁(Warren Wan)是一位資深專家,在膳食補充劑供應鏈領域擁有豐富經驗,並在膠原蛋白肽、骨湯蛋白及角蛋白等核心成分的研發、製程控制及全球採購方面具備深厚的實務經驗。 身為本專欄的作者,他致力於剝去行銷包裝的表象,將晦澀難懂的成分科學與生產品質控制標準,轉化為淺顯易懂的硬核科普,協助讀者看清標籤背後的真相,並做出更理性的健康選擇。.



